HotSpot Therapeutics Set to Unveil Promising IRF5 Data at FOCIS 2025 in Boston HotSpot Therapeutics will showcase preclinical findings from its IRF5 program at FOCIS 2025, emphasizing innovative drug discovery targeting autoimmune diseases.

HotSpot Therapeutics Set to Unveil Promising IRF5 Data at FOCIS 2025 in Boston #USA #Boston #HotSpot_Therapeutics #IRF5_Program #FOCIS_2025